Exam 3 Flashcards
(49 cards)
1
Q
Phenobarbital
A
- 1st anti-seizure;cheap/effective
- MonoTx: Gen TC, Partial, IV for Status Epilepticus
- Effect: Synaptic inhibition via GABA
- SE: Sedation (adults), hyperactive (kids), increased Rx metabolism (CYP3A4 induction), minor rash
2
Q
Phenytoin
A
- MonoTx: Gen TC, Partial
- Effect: Prolong rate of recovery for Na VG channels (longer inactive)
- Mostly bound to protein
- drug conc incr disproportionally to dosage
- liver meta
- SE: Warfarin meta affected; induction of CYP3A4; 20% gingival hyperplasia; minor rash
- SJS: immune response; blistering; 5% mort; flu-like w/ fever - TX discont. RX; TEN is more severe SJS
3
Q
Fosphenytoin
A
IV Prodrug for Status Epilepticus
4
Q
Carbamazepine
A
- MonoTx: Gen TC, Partial, Manic-Dep, Nocicep Pain
- Effect: Prolong rate of recovery for Na VG channels (longer inactive)
- Self-meta to 10,11 epoxide; wait 3 wks for level plasma conc.
- Increase metabolism: phenobarbitol, phenytoin, valproic acid
- SE: acute (stupor, coma, hyperirritable convulsions) and chronic (drowsy, vertigo, ataxia, blurred vision)
- CYP3A4 induction
5
Q
Oxcarbazepine
A
- Mono/Adjunct Tx: Partial (Mono = 4-16yo)
- Effect: Prolong rate of recovery for Na VG channels (longer inactive)
- Prodrug -> active via liver; Inactive via glucoronide conj; renal excretion
- NO SELF INDUCTION
- SE: dizzy, nausea, somnolence, ataxia
- CYP3A4 induction (less than carbamazepine)
6
Q
Ethosuximide
A
- MonoTx: Absence
- Effect: Inhibit T-type Ca Channels
- No plasma protein binding
- few Rx interactions
- 25% urine excretion
- SE: nausea, vomit, anorexia, CNS: drowsy, lethargy, euphoria, SJS, aplastic anemia
7
Q
Valproic Acid
A
- BROAD SPECTRUM AED
- MonoTx: Absence, myclonic, partial, TC, status epilepticus (IV)
- Effect: inhibit T-type Ca channel, prolong inactivation Na VG, increase GABA synth (in vitro)
- Plasma protein binding (most), half-life = 15 hrs (decrease with more AEDs)
- SE: GI: nausea, anorexia; CNS: sedation, ataxia, tremor
- Increase hepatic blood enzymes
- Hepatic toxicity <2 yo (on multiple AEDs incl Valproic)
- CYP2C9 inhibition -> increased conc. of phenytoin/phenobarb and displaces phenytoin from protein
8
Q
Gabapentin
A
- GABA bound to lipophilic ring = cross BBB but does NOT bind to GABA receptor
- AdjunctiveTX: Partial (w/ or w/o gen 2˚ seizure) and neuropathic pain (mostly)
- Effect: Bind L-type Ca channel; no change in Ca conductance
- Excreted unchanged in urine (no meta); check renal fxn before using
- SE: fatigue, ataxia
9
Q
Lamotrigine
A
- BROAD SPECTRUM AED
- Mono/Adjunct TX: Partial, Gen TC, Lennox-Gastaut syndrome (LGS)
- Effect: prolong rate of recovery Na VG (longer inactive); inhibit Ca (lesser effect)
- 24-35 hr half-life; shorter with carba, pheno, and primidone (15 hr); reduces Valproate by 25%
- SE: dizzy, ataxia, blurry vision, nausea; rash + SJS with other AEDs
10
Q
Topiramate
A
- BROAD SPECTRUM AED
- Mono/Adjunct TX: Partial, Gen TC, Lennox-Gastaut syndrome (LGS)
- Effect: inhibit Na and AMPA-kainate rec = enchance GABA
- excreted unchanged in urine (mostly)
- SE: ataxia, fatigue, somnolene, wt loss; decrease plasma estradiol/oral contracep conc.
11
Q
Levetiracetam
A
- Adjunct TX: partial, Gen TC (adult), mycolinc (kids), Status Epilepticus (IV)
- Effect: inhibit presynaptic glutamate release
- excreted unchanged in urine (mostly), no liver induction
- Highest safety margin
- rapid dose titration
- SE: somnolence, dizzy, asthenia, no drug-drug interaction
12
Q
Ergotamine tartrate
A
- ACUTE TX MOD->SEV MIGRAINE
- Ergot alkaloid from fungus (contaiminated Rye)
- Oral, sublingual, suppository (sub/supp bypass portal circ); Max dose = 6mg/attack; 10mg/wk; HL ~ 2hr
- Caffeine prolongs vasconstriction (VC) + inc GI abs
- Liver meta; bile excrete
- Effect: 5-HT1 stim + direct VC on dilated vessels -> dec pulsations -> dec neuro inflam via dec release of VD/pro inflam neuropeptides BUT also interacts with catecholamines, seratonin, and DA receptors
- SE: nausea, vomiting, anorexia (CRTZ activation); TX w/ Metoclopramide (anti-emetic)
- No erythromycin (interferes w/ liver meta of Ergot -> toxicity)
- Contra: PVD (VC + partial a-adren/5-HT2 agonist); B-block prolong VC, CVD, sepsis, liver/kidney dz, preggo/breast feed
13
Q
Dihydroergotamine
A
- ACUTE TX MOD -> SEV MIGRAINE
- semisynth ergot alkaloid
- Liver meta, 10% urine excrete, rest in feces (bile)
- Parenteral admin; incomplete GI absorption (new nasal spray, too)
- Effects: 5-HT1 stim + direct VC on dilated vessels -> dec pulsations -> dec neuro inflam via dec release of VD/pro inflam neuropeptides BUT also interacts with catecholamines, seratonin, and DA receptors
- SE: nausea/vomit -> CRTZ stim; transient bradycardia, leg weakness, vasospasm
- Contra: CVD, sepsis, liver/kidney dz, arterial insuff., preggo/breast feed
14
Q
Methysergide maleate
A
- Prophylactic for migraine/cluster; only if other tx fails
- Semisynth ergot; liver meta to active metabolite (methylergometrine)
- oral w/ meals (vascular HA)
- Effect: 5-HT1 agonist, 5-HT2 antagonist; 1-2d to protective blood level of active metabolite
- SE:
- Fibrosis: retroperitoneal ->obs urinary tract; pleuropulmonary; cardiac -> vascular shutdown; avoid by stopping drug 4 wks every 6 mo
- CV: angina via VC/coronary insuff.
- GI: nausea, vomit, dirrhea, heartburn
- CNS: drowsy, insomnia, hyperactivity, LSD-like
- Contra: CVD, fibrotic dz, liver/kidney dz, peptic ulcer, sepsis, preggos, kids
15
Q
Sumatriptan
A
- ACUTE TX MOD -> SEV MIGRAINE
- 1st gen triptan
- 5-HT derivative
- SubQ or Oral
- MAO-A meta, urine excrete
- Effect: VC of diltated intracranial vessels and inhibit release of VD/proinflamm mediators from CN V; relief for nausea, vomiting, photophobia, phonophobia
- SE: CV (coronary spasm, MI, vent arrythmias); SubQ -> MI .: not for pt w/ CAD; Not IV -> Vasospasm (or w/ ergot b/c inc vasospasm); injection site rxn; triptan symptoms (chest/throat tightness, difficulty breathing, panic/anxiety, paresthesias, heavy feeling)
- Contra: MAOIs w/n 2 wks
16
Q
Zolmitriptan
A
- 2nd gen triptan
- Effect: trigeminovascular system (direct VC, inhibit release of VD/proinflamm mediators) and inhibit pain transmission from trigeminal nuc (high lipid solubility)
- longer half-life than Sumatriptan
- Contra: use w/ MAOI
17
Q
Metoclopramide
A
- DA agonist
- TX acute migraine unresponsive to sumatriptan, DHE, or oral analgesics
- relieve HA and anti-emetic
18
Q
Prochlorperazine
A
- DA agonist
- TX acute migraine unresponsive to sumatriptan, DHE, or oral analgesics
- relieve HA and anti-emetic
19
Q
Midrin
A
- TX MILD -> MOD MIGRAINE
- As effective as oral Ergot., less SEs
- 2 caps immediately, and 1/hr until no HA (>6/d)
- Isometheptene -> a/B adren activity (mild VC)
- dichloralphenazone -> sedative
- Acetaminophen
- Contra: glacucoma, renal dz, HTN, heart/liver dz, MAOIs
20
Q
Propranalol, timolol, atenolol, metropolol, nadolol
A
- NOT partial agonists
- Prophylaxis
- SE:
- fatigue
- cold extremities
- dizzy
- CNS SE (vivid dreams, nightmares, insomnia, depression)
- Nadalol/Atenolol - less CNS effects than Propr
- Contra: asthmatics/DM; VC may enhance effect of ergotamine
21
Q
Amitrptyline
A
- Effect: downreg centreal 5-HT2 + adrenergic receptors; ind of antidepressant effects
- Prophylaxis
- SE
- Anticholinergic (dry mouth, blurry vision, urine retention, cardiac arrhythmia)
- Contra: glaucoma, BPH, heart dz
22
Q
Valproate, topiramate, gabapentin
A
- Prophylaxis (dec frequency by 50% in most pts)
- Effect: inc GABA transmission, mod glutamate channel activity, and inibiting Na/Ca channels
- SE: nausea, vomit, weakness, wt gain, tremor, hair loss, hepatic tox (rare)
- Contra: liver dz, thrombocytopenia
- Valproic Acid: neural tube defects
- Topiramate/Gabapentin effective tx
- Top SE: paresthesia, fatigue, anorexia, diarrhea, wt loss, memory problems, nausea
- Gaba SE: somnolence, asthenia, dizzy
23
Q
Migraine Triggers
A
- Weather change
- Alcohol
- Chocolate
- Tyramine (cheese, sour cream, wine, beer, liver, bananas, avocado, chocolate, yogurt, bean pods)
24
Q
Morphine
(Mechanism)
A
- active moiety: phenyl-N-methyl piperidine
- antagonist activity: allyl/methylcclopropyl @ p 17
- acts on limbic system -> mod perception of pain .: pain does not evoke anxiety, fear, panic, or suffering
- acts on SC/thalamus -> mod physio pain
- dec sensitivity of noci fields
- effective against: dull, constant, visceral pain
- No LoC @ therapeutic dose
- Agonist on receptors for endorphins/enkephalins/dynorphins -> mod pain processing
- strong u agonist, mod k agonist, weak d agonist
25
Morphine
| (Actions/Effects/SE)
* Analgesia (see mech card)
* Sedation and mental clouding - "floating/dream-like but normally aroused"; help sleep by pain removal NOT depression
* OD situation: sedation -\> hypnosis/stupor -\> coma -\> death
* Relief of anxiety and apprehension
* Euphoria (usually)/Dysphoria (occasionally; more common in the ladies)
* Nausea - CRTZ stim but eventual tolerance
* Respiratory Depression - dec CO2 sens in medulla; major toxic effect -\> OD death
* Partial relief to acute PE -\> dec awareness of resp distress; + VD -\> dec pre-/afterload
* Pupil constriction: "pin point" -\> OD sign
* Antitussive effect: medulla
* Histamine release -\> aggre asthma/COPD or cause itching; Tx w/ H1 antagonist (dephenhydramine) or naloxone
* Dec seizure threshold
* Endocrine changes: dec sec gonadotropins, corticosteroids, prolactin; mentrual change (women) + impotence (men)
* SM: incr tone circ sm and dec propulsive movement of long m.
* dec GI motility (constipation), urine retention, bronchoconstriction, incr biliary pressure (bile duct constrict)
* CV: ortho hypotension (histamine release); cute VD (histamine release), incr CSF (CO2 incr + cerebral VD)
* Skeletal M. rigidity -\> high dose
* Immunosupp: chronic usage
26
Morphine
| (dose/admin route/interactions)
* SEVERE PAIN
* IM/IV; oral available but not as effective b/c 1st pass meta; 90% urine excrete in 24h
* Dose: 10 mg SC/IM or 10-30 mg P.O; higher may be needed
* Important: infusion/autoinjector; PCA (reduces usage of drug); spinal analgesia
* 4-6h duration
* crosses placenta
* Interactions:
* additive w/ CNS depressants, MAOIs (hyperpyrexia), abuse w/ amphetamines/cocaine, combo w/ other drugs for enhanced analgesia, antihistamines (enhance analgesic effect -\> not used anymore), tricyclics (enhanced analagesic effect)
27
Codeine
* MILD-\>MOD
* Oral
* 1/12 as potent as morphine; 30-60 mg P.O
* antitussive
* Codeine weak opioid but when demethylated -\> forms morphine -\> effects
28
Hydromorphone
* similar to morphine; more potent
* Trauma, post-op, interchangeable w/ morphine
29
Oxycodone
* MOD-\>SEV
* morphine/codeine mix
* oral
* OxyContin = sustained release; widely abused; "Hillbilly Heroin"
30
Hydrocodone
* MILD -\> MOD
* similar to codeine/oxycodone
* Oral combo w/ acetaminophen
* antitussive
* widely prescribed
31
Meperidine
* MOD -\> SEV
* synthetic
* oral/parenteral
* 1/10 as potent as morphine
* Used in Obstetrics (doesn't effect fetus as much)
* use for acute not chronic (build up of metabolite -\> seizures)
* Rx interaction w/ MAOI/SSRI
32
Heroin
* more potent/more euphoric than morphine; 4-6hr duration
* abuse
* injection, snorting, smoking
33
Methadone
* Oral; less 1st pass than morphine
* Low euphoria, long duration (12-24hr)
* analgesic (acute), tx opioid addiction (chronic use)
34
Fentanyl
* NOT oral -\> 1st pass
* potent u agonist
* parenterally (surgery), transdermal (chronic pain), lozenge (breakthrough tx)
* fentanyl + droperidol -\> neuroleptic analgesia (for Dx/minor surgeries)
* fentanyl + droperidol + NO -\> neuroleptic anesthesia
35
Pentazocine
* Mixed
* k agonist, partial u (antagonist @ high dose)
* less effective, less sedation/resp dep, less physical dependence
* more CNS stim (hallucinations)
* precipitate withdrawl in addicts
* Pentazocine + nalaxone (NX) reduce IV abuse
36
Butorphanol
* similar to pentazocine, parenterally/intranasally
37
Buprenorphine
* partial u agonist (antagonist @ high dose)
* very low abuse potential, less analgesic effect
* dec Rx craving in addicts
* some contain nalaxone to prevent IV abuse
* injection, sublingual, intranasally, transdermal
* "Office based" tx for addiction
38
Tramadol
* MILD-\>MOD
* weak u agonist
* inhibit NE/5-HT reuptake like tricyclics
* mild SEs (similar to morphine)
* low abuse/addiction (but still present)
39
Naloxone
* Tx OD; reverse resp dep
* parenterally (not oral b/c first pass)
* combo w/ oral narcotics to prevent abuse
* short action (1-2 hr)
* precipitate withdrawl
40
Naltrexone
* Oral, long lasting (24hr)
* "immunize" addicts = no "high"
* Heptatox risk
* pt compliance = problem
* Dec EtOH craving in alcoholics = main use now
41
Methylnaltrexone
* quaternary salt of naltrexone
* tx/prevent constipation (opioid use)
* parenterally
* tx post-op paralytic ileus
42
Alvimopan
* similar to methylnaltrexone but oral efficacy
43
NSAIDs (Indomethacin, Ibuprofen, Ketorolac)
* antiinflammatory
* can stop gout attack
* inhibit PG synth
* SE: GI irritation (inhibits protective mech in stomach -\> acid irritation); caution w/ peptic ulcer
* indomethacin = CNS effects (HA, drowsy, dizzy, confusion)
* Ketoralac = IM, tx severe/acute attacks
* avoid use w/ aspirin (biphasic effect on uric acid secr.)
44
Corticosteroids (Prednisone and methylprednisone)
* quick/effective but immunosuppression
45
Colchicine
* antiinflammatory specific for gout; not widely used anymore
* Oral/IV (acute attack); low/less frequent dose = prevent recurrence
* binds tubulin -\> prevents polymerization -\> decr leukocyte migration/phago/mitosis
* inhibits prodution/release of proinflamm glycoproteins from neutrophils
* SE: GI (Severe; NVD), OD (severe burning, throat pain, bloody diarrhea and CNS dep.), transient leukopenia, agranulocytosis, aplastic anemia, alpecia, myopathies/neuropathies (chronic use)
46
Allopurinol
* Effect: inhibitxanthine oxidase -\> decr uric acid formation (keeps from forming .: facilitates dissolution)
* reduces gout attack potential (not acute tx)
* SE: initial incr in gout attacks; elevated liver enzymes, allergic rxn (skin)
* Drug interactions: incr half-life/effect of probenecid; inhib hepatic meta of some drugs; incr half-life theophyline
* Surgery -\> cell lysis -\> purine release -\> gout attack (tx w/ allo)
47
Febuxostat
* xanthine oxidase inhibitor
* SE: less skin problems/allergic rxns; elevated liver enzymes
* high cost
* beneficial if allopurinol failure
48
Probenecid
* Oral (2-4hr; elim 5-8hr)
* Chronic NOT acute tx
* Effect: inhibits secretion/reabsorption of organic acids -\> net effect = uric acid excretion
* SE: GI upset (caution w/ peptic ulcer); skin rash, OD CNS effects (seizure/death), incr kidney stone effect
* Contra: gouty nephropathy
* Rx interactions: salicylates, inhib rx excretion (penicillin, methotrexate, NSAIDS, rifampin in bile)
49
Acetaminophen
* inhibit PG @ CNS not PNS
* NO antiinflamm
* NO GI SEs
* SE: hepatotox @ high dose